First Time Loading...

Fusion Antibodies PLC
LSE:FAB

Watchlist Manager
Fusion Antibodies PLC Logo
Fusion Antibodies PLC
LSE:FAB
Watchlist
Price: 3.4 GBX
Updated: May 14, 2024

Fusion Antibodies PLC
Accounts Payable

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Fusion Antibodies PLC
Accounts Payable Peer Comparison

Comparables:
ONT
O
ORPH
DXRX
ERGO
HVO

Competitive Accounts Payable Analysis
Latest Figures & CAGR of Competitors

Company Accounts Payable CAGR 3Y CAGR 5Y CAGR 10Y
Fusion Antibodies PLC
LSE:FAB
Accounts Payable
£537k
CAGR 3-Years
-4%
CAGR 5-Years
1%
CAGR 10-Years
N/A
Oxford Nanopore Technologies PLC
LSE:ONT
Accounts Payable
£78.4m
CAGR 3-Years
36%
CAGR 5-Years
49%
CAGR 10-Years
N/A
O
Open Orphan PLC
LSE:ORPH
Accounts Payable
£2.7m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Diaceutics PLC
LSE:DXRX
Accounts Payable
£759k
CAGR 3-Years
38%
CAGR 5-Years
33%
CAGR 10-Years
N/A
Ergomed PLC
LSE:ERGO
Accounts Payable
£4.3m
CAGR 3-Years
23%
CAGR 5-Years
2%
CAGR 10-Years
N/A
hVIVO PLC
LSE:HVO
Accounts Payable
£34.2m
CAGR 3-Years
17%
CAGR 5-Years
72%
CAGR 10-Years
55%

See Also

What is Fusion Antibodies PLC's Accounts Payable?
Accounts Payable
537k GBP

Based on the financial report for Sep 30, 2023, Fusion Antibodies PLC's Accounts Payable amounts to 537k GBP.

What is Fusion Antibodies PLC's Accounts Payable growth rate?
Accounts Payable CAGR 5Y
1%

Over the last year, the Accounts Payable growth was -49%. The average annual Accounts Payable growth rates for Fusion Antibodies PLC have been -4% over the past three years , 1% over the past five years .